Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor

EMBO Journal

Volumn 17, Issue 13, 1998, Pages 3534-3541

  Swope, Melissa ^a   Sun, Hong Wei ^a   Blake, Paul R ^b   Lolis, Elias ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

Cytokine; Enzyme; Macrophage migration inhibitory factor; NMR; Protein structure

Indexed keywords

CYTOKINE; GLYCINE; MACROPHAGE MIGRATION INHIBITION FACTOR; PHENYLPYRUVIC ACID; PROLINE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; ENZYME ACTIVE SITE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATALYSIS; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PHENYLPYRUVIC ACIDS; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

EID: 0032127485     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.13.3534     Document Type: Article

References (37)

1. Bacher, M., Metz, C., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T. and Bucala, R. (1996) An essential role for MIF in T cell activation. Proc. Natl Acad. Sci. USA, 93, 7849-7854.
2. Bernhagen, J., Calandra, T., Mitchell, R.A., Martin, S.B., Tracey, K.J., Voelter, W., Manogue, K.R., Cerami, A. and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature, 365, 756-759.
3. Bernhagen, J., Mitchell, R.A., Calandra, T., Voelter, W., Cerami, A. and Bucala, R. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration factor (MIF). Biochemistry, 33, 14144-14155.
4. Bernhagen, J., Bacher, M., Calandra, T., Metz, C., Doty, S.B., Donnelly, T. and Bucala, R. (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J. Exp. Med., 183, 277-282.
5. Bloom, B.R. and Bennett, B. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science, 153, 80-82.
6. Brunger, A.T. (1992) Free R-value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature, 355, 472-475.
7. Calandra, T., Bernhagen, J., Metz, C.N., Spiegel, L., Bacher, M., Donnelly, T., Cerami, A. and Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature, 377, 68-71.
8. Chaput, M., Claes, V., Portetelle, D., Cludts, I., Cravador, A., Burny, A., Gras, H. and Tartar, A. (1988) The neurotropic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature, 332, 454-455.
9. Chook, Y.M., Gray, J.V., Ke, H. and Lipscomb, W.N. (1994) The monofunctional chorismate mutase from Bacillus subtilis. Structure determination of chorismate mutase and its complexes with a transition state analog and prephenate, and its implications for the mechanism of the enzymatic reaction. J. Mol. Biol., 240, 476-500.
10. David, J.R. (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl Acad. Sci. USA, 56, 72-77.
11. Deutsch, J. (1997) Determination of p-hydroxyphenylpyruvate, p-hydroxyphenyllactate and tyrosine in normal human plasma by gas chromatography-mass spectrometry isotope-dilutions assay. J. Chromatogr., B690, 1-6.
12. Devereux, J., Haeberli, P. and Smithies, O. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res., 12, 387-395.
13. Galat, A., Riviere, S. and Bouet, F. (1993) Purification of macrophage migration inhibitory factor from bovine brain cytosol. FEBS Lett., 319, 233-236.
14. Guthrie, L., McPhail, L., Henson, P. and Johnston, R. (1984) Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. J. Exp. Med., 160, 1656-1671.
15. Hajipour, G., Johnson, W.H., Dauben, P.D., Stolowich, N.J. and Whitman, C.P. (1993) Chemical and enzymatic ketonization of 5-(carboxymethyl)-2-hydroxymuconate. J. Am. Chem. Soc., 115, 3533-3542.
16. Hoogewerf, A., Leone, J., Reardon, I., Howe, J., Asa, D., Heinrikson, R. and Ledbetter, S. (1995) CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem., 270, 3268-3277.
17. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S.F. and Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science, 261, 466-469.
18. Kato, Y., Muto, T., Tomura, T., Tsumura, H., Watarai, H., Mikayama, T., Ishizaka, K. and Kuroki, R. (1996) The crystal structure of human glycosylation-inhibition factor is a trimeric barrel with three 6-stranded beta sheets. Proc. Natl Acad. Sci. USA, 93, 3007-3010.
19. Laskowski, R.A., MacArthur, M.W., Moss, D. and Thornton, J.M. (1993) Procheck: a program to check the stereochemical quality of protein structure. J. Appl. Crystallogr., 26, 283-291.
20. Leiva, M.C. and Lyttle, C.R. (1992) Leukocyte chemotactic activity of FKBP and inhibition of FK506. Biochem. Biophys. Res. Commun., 186, 1178-1183.
21. McNamara, M.J., Norton, J.A., Nauta, R.J. and Alexander, H.R. (1993) Interleukin-1 receptor antibody protection and treatment against lethal endotoxemia in mice. J. Surg. Res., 54, 316-321.
22. Mikayama, T. et al. (1993) Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc. Natl Acad. Sci. USA, 90, 10056-10060.
23. Muhlhahn, P., Bernhagen, J., Czisch, M., Georgescu, J., Renner, C., Ross, A., Bucala, R. and Holak, T.A. (1996) NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor (MIF). Protein Sci., 5, 2095-2103.
24. Okusawa, S., Gelfand, J.A., Ikejima, T., Connolly, R.J. and Dinarello, C.A. (1988) Interleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest., 81, 1162-1172.
25. Rosengren, E., Bucala, R., Arnan, P., Jacobsson, L., Odh, G., Metz, C.N. and Rorsman, H. (1996) The immunoregulatory macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med., 2, 143-149.
26. Rosengren, E., Aman, P., Thelin, S., Hansson, C., Ahlfors, S., Bjork, P., Jacobsson, L. and Rorsman, H. (1997) The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett., 417, 85-88.
27. Sherry, B., Yarlett, N., Strupp, A. and Cerami, A. (1992) Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc. Natl Acad. Sci. USA, 89, 3511-3515.
28. a values of active site residues. Biochemistry, 35, 814-823.
29. Subramanya, H.S., Roper, D.I., Dauter, D., Dodson, E.J., Davies, G.J., Wilson, K.S. and Wigley, D.B. (1996) Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry, 35, 792-802.
30. Sun, H.W., Bernhagen, J., Bucala, R. and Lolis, E. (1996a) Crystal structure at 2.6 Angstrom resolution of human macrophage migration inhibitory factor. Proc. Natl Acad. Sci. USA, 93, 5191-5196.
31. Sun, H.W., Swope, M., Cinquina, C., Bedarkar, S., Bernhagen, J., Bucala, R. and Lolis, E. (1996b) Subunit structure of human migration inhibitory factor: evidence for a trimer. Protein Eng., 9, 631-635.
32. Suzuki, M., Sugimoto, H., Nakagawa, A., Tanaka, I., Nishihara, J. and Sakai, M. (1996) Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Struct. Biol., 3, 259-266.
33. Tracey, K.J. et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470-474.
34. Tracey, K.J., Fong, Y., Hesse, D.G., Manogue, K.R., Lee, A.T., Kuo, G.C., Lowry, S.F. and Cerami, A. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330, 662-664.
35. Vu, T., Wheaton, V., Hung, D., Charo, I. and Coughlin, S. (1991) Domains specifying thrombin-receptor interaction. Nature, 353, 674-677.
36. Whitman, C.P., Aird, B.A., Gillespie, W.R. and Stolowich, N.J. (1991) Chemical and enzymatic ketonization of 2-hydroxymuconate, a conjugated enol. J. Am. Chem. Soc., 113, 3154-3162.
37. Xu, Q., Leiva, M.C., Fischkoff, S.A., Handschumacher, R.E. and Lyttle, C.R. (1992) Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem., 267, 11968-11971.